News
VVOS
2.840
+7.58%
0.200
Weekly Report: what happened at VVOS last week (0421-0425)?
Weekly Report · 2d ago
Weekly Report: what happened at VVOS last week (0414-0418)?
Weekly Report · 04/21 12:17
Vivos To Acquire Operating Assets Of The Sleep Center Of Nevada
NASDAQ · 04/16 12:47
Vivos Therapeutics announces agreement to acquire operating assets of SCN
TipRanks · 04/16 12:36
*Vivos Therapeutics Acquisition Expected to Close Later This Qtr or in the 3Q >VVOS
Dow Jones · 04/16 12:32
VIVOS THERAPEUTICS INC: TO PAY UP TO $9 MLN FOR SCN OPERATING ASSETS
Reuters · 04/16 12:30
*Vivos Therapeutics Signs Definitive Agreement To Acquire Largest Sleep Center Operator In Nevada >VVOS
Dow Jones · 04/16 12:30
Press Release: Vivos Therapeutics Signs -2-
Dow Jones · 04/16 12:30
Vivos Therapeutics Is Maintained at Buy by Ascendiant Capital
Dow Jones · 04/15 10:02
Vivos Therapeutics Price Target Cut to $6.20/Share From $6.60 by Ascendiant Capital
Dow Jones · 04/15 10:02
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2
Benzinga · 04/15 09:52
Weekly Report: what happened at VVOS last week (0407-0411)?
Weekly Report · 04/14 12:03
Weekly Report: what happened at VVOS last week (0331-0404)?
Weekly Report · 04/07 12:02
Vivos Therapeutics’ Earnings Call Highlights Growth and Expansion
TipRanks · 04/02 00:09
Vivos Therapeutics price target lowered to $5.50 from $6 at Alliance Global Partners
TipRanks · 04/01 13:26
Vivos therapeutics outlines expansion of sleep center alliances with $4,500 revenue per patient potential
Seeking Alpha · 04/01 04:18
Vivos Therapeutics Reports Revenue Growth and Strategic Shift
TipRanks · 04/01 03:58
Unfortunately, the provided text does not contain a title for the article. It appears to be a financial report or a set of financial statements in a machine-readable format, such as XBRL (eXtensible Business Reporting Language).
Press release · 03/31 23:18
Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates
NASDAQ · 03/31 22:55
Vivos Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 03/31 22:31
More
Webull provides a variety of real-time VVOS stock news. You can receive the latest news about Vivos Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About VVOS
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective non-invasive, non-surgical, non-pharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. It comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service, and others.